Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial

Research output: Contribution to journalArticlepeer-review


  • David A. Jones
  • Pankaj Mistry
  • Matthew Dalby
  • Tessa Fulton-Lieuw
  • Janet Dunn
  • Alastair M. Gray


Original languageEnglish
JournalEuropean Journal of Cancer
Publication statusPublished - 1 Jan 2020